Chemically Defined and Small Molecule-Based Generation of Human Cardiomyocytes

• Published in: Nature methods Vol. 11; no. 8; pp. 855 - 860
• Main Authors: Burridge, Paul W., Matsa, Elena, Shukla, Praveen, Lin, Ziliang C., Churko, Jared M., Ebert, Antje D., Lan, Feng, Diecke, Sebastian, Huber, Bruno, Mordwinkin, Nicholas M., Plews, Jordan R., Abilez, Oscar J., Cui, Bianxiao, Gold, Joseph D., Wu, Joseph C.
• Format: Journal Article
• Language: English
• Published: 15.06.2014
• ISSN: 1548-7091; 1548-7105
• DOI: 10.1038/nmeth.2999

Existing methodologies for human induced pluripotent stem cell (hiPSC) cardiac differentiation are efficient but require the use of complex, undefined medium constituents that hinder further elucidation of the molecular mechanisms of cardiomyogenesis. Using hiPSCs derived under chemically defined conditions on synthetic matrices, we systematically developed a highly optimized cardiac differentiation strategy, employing a chemically defined medium consisting of just three components: the basal medium RPMI 1640, L-ascorbic acid 2-phosphate, and rice-derived recombinant human albumin. Along with small molecule-based differentiation induction, this protocol produced contractile sheets of up to 95% TNNT2 + cardiomyocytes at a yield of up to 100 cardiomyocytes for every input pluripotent cell, and was effective in 11 hiPSC lines tested. This is the first fully chemically defined platform for cardiac specification of hiPSCs, and allows the elucidation of cardiomyocyte macromolecular and metabolic requirements whilst providing a minimally complex system for the study of maturation and subtype specification.